scpharmaceuticals.com (SCPH) Forvard P/S multiplikatori
scPharmaceuticals Inc. nasos ishlab chiqarishni tashqi hamkorlarga autsorsing qilish orqali asosiy ekologik standartlarga rioya qilmoqda. Kutilayotgan narx-sotuvlar nisbati bozor kutganlarini vizuallashtiradi, bunda 6.00 ushbu metrikaning joriy qiymatini ko'rsatadi. scPharmaceuticals Inc. yurak yetishmovchiligini uy sharoitida davolash uchun Furoscix tizimini joriy etmoqda, bu esa shifoxona xarajatlarini kamaytiradi. Kompaniyaning innovator sifatidagi maqomi va kardiologlarning ishonchi ushbu terapiyaning bemorlar uchun yuqori qiymatini tasdiqlaydi.
scpharmaceuticals.com (SCPH) kompaniyasi koʻrsatkichlari kesimi va tahlili
- bozor narxi va tahlilchilarning maqsadli narxlari:
- bozor kapitallashuvi tafsilotlari:
- emitentning balans qiymati statistikasi:
- qarzdorlik darajasi va moliyaviy likvidlik ma'lumotlari:
Umumiy qarzning kapitalga nisbati scPharmaceuticals Inc.|SCPH - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati scPharmaceuticals|SCPH - Jamlangan qarz majburiyatlari|Qarzning balans kapitallashuviga nisbati scPharmaceuticals Inc.|SCPH - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzlari scPharmaceuticals|Tezkor likvidlik koeffitsiyenti scpharmaceuticals.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
SCPH - Sof daromad|Prognoz qilingan kelajakdagi foyda scPharmaceuticals Inc.|SCPH - Kapitalizatsiyaning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati scPharmaceuticals|SCPH - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti scPharmaceuticals Inc.|SCPH - Kompaniyaning soliqlar, foizlar va amortizatsiyadan oldingi foydasi|Bir aksiya uchun sof foyda (EPS TTM) scPharmaceuticals|SCPH - So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda|Choraklik EPS foyda o'sishi scpharmaceuticals.com|SCPH - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi scPharmaceuticals Inc.
- sotuv hajmi va tushum haqida ma'lumot:
Kompaniyaning jamlanma tahlili:SCPH (scPharma)
Ushbu ko'rsatkich scPharmaceuticals Inc. (SCPH) kompaniyasining joriy bozor kapitalizatsiyasini prognoz qilingan daromadlar bilan solishtirib, kelajakdagi o'sish uchun premiumni va aktivning potentsial sotib olish qiymatini aniqlaydi. Uy sharoitida yurak yetishmovchiligini davolash segmentining kengayishi fonida, taxminiy forward P/S ko'rsatkichi bozor shifoxonaga yotqizish xarajatlarini kamaytirish samaradorligini qanday baholashini aks ettiradi, bu esa investorlarga biznesning qadrsizlanganini yoki operatsion xatarlarni aniqlash imkonini beradi.
scPharmaceuticals Inc. (SCPH) raqobatchilari
Narxning prognoz qilingan daromadga nisbati Haleon HLN|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Kenvue Inc (KVUE)|Verona Pharma Corp - Forvard P/S multiplikatori|Jyong Bio (MENS) - Forvard narx/daromad multiplikatori|Ligand Pharmaceuticals (LGND) - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati AMRX (amneal.com)|PRGO (Perrigo) - Forvard P/S multiplikatori|ALVO: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori LQDA|Forvard P/S multiplikatori Galapagos Corp (GLPG)|Narxning prognoz qilingan daromadga nisbati ANI Pharmaceuticals ANIP|Sotuvga nisbatan forvard narx MNKD|AMPH - Narxning prognoz qilingan daromadga nisbati|Pacira Pharmaceuticals (PCRX) - Forvard narx/daromad multiplikatori|SPRY: Forvard P/S multiplikatori|Theravance Corp (TBPH) - Forvard P/S multiplikatori|AQST (Aquestive Therapeutics) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Tectonic (TECX)|Forvard P/S multiplikatori TNXP|SXTC - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Eupraxia Pharmaceuticals Inc. - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori BioHarvest Sciences Inc BHST|EXOZ: Forvard narx/daromad multiplikatori|Oramed Pharmaceuticals - Narxning kutilayotgan daromadga nisbati|ENTX: Forvard P/S multiplikatori|HYFT - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|ABVC (ABVC BioPharma Inc) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Cumberland Corp (CPIX)|Forvard P/S multiplikatori QNTM|Forvard P/S multiplikatori fibrogen.com (FGEN)|Narxning prognoz qilingan daromadga nisbati Telomir Pharmaceuticals, Inc. TELO|Rani Therapeutics Holdings - Narxning prognoz qilingan daromadga nisbati|SNYR - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Rallybio Corporation RLYB|LEXX (lexariabioscience.com) - Forvard narx/daromad multiplikatori|pulmatrix.com - Sotuvga nisbatan forvard narx|PTHL (Pheton Holdings Limited) - Forvard P/S multiplikatori|Aptorum (APM) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Lyra Therapeutics, Inc (LYRA)|Impact BioMedical, Inc. - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Forvard P/S multiplikatori TNFA (TNF Pharmaceuticals, Inc.)|YCBD - Forvard narx/daromad multiplikatori|PRFX: Forvard narx/daromad multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Altamira Therapeutics CYTO|Lipella (LIPO) - Narxning prognoz qilingan daromadga nisbati|OPTN - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|PIRS (Pieris Pharmaceuticals) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori procapsgroup.com (PROC)|Narxning prognoz qilingan daromadga nisbati Petros Pharmaceuticals, Inc. (PTPI)|QLI: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori SLRN (ACELYRIN, Inc.)|Sotuvga nisbatan forvard narx TFFP
